Brief 15 minute presentations from companies developing peptide therapeutics and related technologies. This rapid and compressed format is designed for quick introduction between symposium participants to new technologies, and companies. Each presentation is structured to highlight the value of the technology or therapeutic being offered and the business strategy.
Alan Kopin
Co-founder
On Target Therapeutics
Joyce Lonergan
CEO and co-founder
Mellitus, LLC
Gary Olson
President & CEO
Provid Pharmaceuticals Inc.
Kent Werner
CEO
Cogentis Therapeutics
Tarik Soliman
Founder
Extend Biosciences
Mark McLaughlin
Executive Vice President
Modulation Therapeutics Incorporated
George Tocco
Director of Business Development
VECT-HORUS
David Diller
Director of Computational Chemistry
CMDBioscience Inc.
Pete Mariner
Director of Wound Healing
Mosaic Biosciences
Barry O'Connor
Research and Development Manager
Jitsubo Co. Ltd
Lisa Ganley-Leal
Director of Infectious Diseases and Vaccine Development
STC Biologics, Inc.
Robert Hammer
Senior Principal Scientist & Group Leader
Ra Pharmaceuticals
Alexander Sigalov
President
SignaBlok, Inc.
